# US 2024/0390145 A1 · Systems and methods for deploying devices into cardiac tissue

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0390145 A1
- Document ID: US20240390145A1
- Status: Published application
- Kind: A1
- Application number: 18/645,348
- Filed: 2024-04-24
- Published: 2024-11-28
- Earliest claimed: 2023-04-24
- Applicants: Ancora Heart, Inc.
- Inventors: Russel M. SAMPSON
- Web page: https://patentgrep.com/patent/US20240390145A1

## CPC

- A61B 5/0215: by means inserted into the body
- A61F 2/2466: {Delivery devices therefor}
- A61B 18/1492: {having a flexible, catheter-like structure, e.g. for heart ablation (A61B18/1477 takes precedence)}
- A61F 2/2457: {Chordae tendineae prostheses}
- A61L 27/16: obtained by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/52: Hydrogels or hydrocolloids
- A61B 2017/00243: {cardiac}
- A61L 2430/20: for reconstruction of the heart, e.g. heart valves
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

This application generally relates to systems and methods for synchronizing deployment of various devices into cardiac tissue with an ECG waveform. The systems and methods may include use of a pressurized gas to actuate deployment and anchoring of the devices, e.g., implants configured to reshape a heart ventricle, into cardiac tissue. Deployment of the devices may occur during a portion of the cardiac cycle in which myocardial tissue may be at its thickest, e.g., at the end of systole.

## Claims

### Claim 1

A system for deploying a device into tissue comprising:
a) a deployment catheter; and
b) a controller comprising one or more processors, wherein the one or more processors is configured to analyze an ECG signal from a patient and issue a control signal to the deployment catheter to deliver the device into one or more target sites of a cardiac tissue, wherein the one or more target sites comprises an area of reduced tissue thickness.

### Claim 2 (depends on 1)

The system of claim 1, wherein the area of reduced tissue thickness is about 4 mm or less during a diastolic portion of a cardiac cycle.

### Claim 3 (depends on 1)

The system of claim 1, wherein the control signal is operable to trigger the deployment catheter to deliver the device therefrom during a target portion of the ECG signal.

### Claim 4 (depends on 3)

The system of claim 3, wherein the target portion of the ECG signal corresponds to an end systolic portion of a cardiac cycle.

### Claim 5 (depends on 3)

The system of claim 3, wherein the target portion of the ECG signal comprises a QRS complex.

### Claim 6 (depends on 3)

The system of claim 3, wherein the target portion of the ECG signal comprises an ST segment.

### Claim 7 (depends on 1)

The system of claim 1, wherein the cardiac tissue comprises a left ventricular tissue.

### Claim 8

(canceled)

### Claim 9 (depends on 1)

The system of claim 1, wherein the cardiac tissue comprises myocardium.

### Claim 10 (depends on 1)

The system of claim 1, wherein the deployment catheter comprises:
a) an elongate shaft;
b) a slider configured to translate along a longitudinal axis of the shaft; and
c) a handle coupled to a proximal end of the shaft and comprising an actuator coupled to a body of the handle, wherein the actuator is configured to deliver the device from a lumen of the catheter according to the control signal.

### Claim 11 (depends on 10)

The system of claim 10, wherein the actuator comprises a cylinder configured to be filled with a pressurized gas selected from the group consisting of oxygen, helium, nitrous oxide, nitrogen, medical air, carbon dioxide, hydrogen, and mixtures thereof.

### Claim 12

(canceled)

### Claim 13 (depends on 10)

The system of claim 10, wherein the actuator comprises a solenoid valve.

### Claim 14

(canceled)

### Claim 15

(canceled)

### Claim 16 (depends on 1)

The system of claim 1, wherein the device comprises an implant including a plurality of anchors coupled to a tether.

### Claim 17

(canceled)

### Claim 18 (depends on 16)

The system of claim 16, wherein the implant further comprises a plurality of force distribution members.

### Claim at position 19

-21. (canceled)

### Claim 22 (depends on 1)

The system of claim 1, further comprising a multi-window catheter.

### Claim 23

(canceled)

### Claim 24 (depends on 1)

The system of claim 1, further comprising a display, the display comprising a manual interface operable by a user to switch the one or more processors to a manual mode in which the user manually controls delivery of the device from the deployment catheter.

### Claim at position 23

-29. (canceled)

### Claim 30

A method for deploying a device into tissue comprising:
a) obtaining an ECG signal from a patient;
b) synchronizing deployment of the device from a deployment catheter with a target portion of the ECG signal; and
c) deploying the device into one or more target sites of a cardiac tissue, wherein the one or more target sites comprise an area of reduced tissue thickness.

### Claim 31 (depends on 30)

The method of claim 30, wherein the area of reduced tissue thickness is about 4 mm or less during a diastolic portion of a cardiac cycle.

### Claim 32 (depends on 30)

The method of claim 30, wherein the target portion of the ECG signal corresponds to an end systolic portion of a cardiac cycle.

### Claim 33 (depends on 30)

The method of claim 30, wherein deployment of the device is synchronized with a QRS complex of the ECG signal.

### Claim 34 (depends on 30)

The method of claim 30, wherein deployment of the device is synchronized with an ST segment of the ECG signal.

### Claim 35 (depends on 30)

The method of claim 30, wherein synchronizing deployment is accomplished using one or more processors configured to analyze the ECG signal and issue a control signal to an actuator of the deployment catheter such that the device is deployed into the one or more target sites during the target portion of the ECG signal.

### Claim 36 (depends on 30)

The method of claim 30, wherein the cardiac tissue comprises a left ventricular tissue.

### Claim 37

(canceled)

### Claim 38 (depends on 30)

The method of claim 30, wherein the cardiac tissue comprises myocardium.

### Claim 39 (depends on 30)

The method of claim 30, wherein deploying the device into the one or more target sites comprises actuating a flow of a pressurized gas selected from the group consisting of oxygen, helium, nitrous oxide, nitrogen, medical air, carbon dioxide, hydrogen, and mixtures thereof.

### Claim 40

(canceled)

### Claim 41 (depends on 30)

The method of claim 30, further comprising reshaping the left ventricular tissue with the device.

### Claim 42

(canceled)

### Claim 43 (depends on 30)

The method of claim 30, wherein the device comprises an implant including a plurality of anchors coupled to a tether.

### Claim 44

(canceled)

### Claim 45 (depends on 43)

The method of claim 43, wherein the implant further comprises a plurality of force distribution members.

### Claim at position 40

-50. (canceled)

### Claim 51 (depends on 43)

The method of claim 43, wherein the deploying the device comprises deploying the plurality of anchors into the cardiac tissue sequentially.

### Claim 52 (depends on 43)

The method of claim 43, wherein the deploying the device comprises deploying the plurality of anchors into the cardiac tissue simultaneously.

### Claim 53

(canceled)

### Claim 54 (depends on 30)

The method of claim 30, further comprising switching from an automatic mode to a manual mode in which the user manually controls deployment of the device from the deployment catheter.

### Claim at position 45

-59. (canceled)
